Literature DB >> 9033259

Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

K S Montine1, S J Olson, V Amarnath, W O Whetsell, D G Graham, T J Montine.   

Abstract

Cumulative oxidative damage, including lipid peroxidation, is a central component of cellular aging and is thought to play a role in the pathogenesis of late-onset Alzheimer's disease (AD). Lipid peroxidation produces several cytotoxic aldehydes, one of the most potent being 4-hydroxy-2-nonenal (HNE). We have shown previously that HNE is a potent neurotoxin that covalently modifies and cross-links neuronal cytoskeletal protein in neuroglial cultures, suggesting that HNE may contribute to the pathogenesis of AD. In addition to aging, inheritance of the epsilon 4 allele of APOE is the other major risk factor for development of late-onset AD; however, the mechanisms through which aging and apolipoprotein E isoforms may collaborate in the onset or progression of AD are not known. We tested the hypothesis that HNE may yield a particular type of protein modification, pyrrole adduction, and that this may contribute to the pathogenesis of AD. Our data demonstrated that HNE formed pyrrole adducts with protein. Polyclonal antiserum was raised that specifically recognized HNE pyrrole adducts, and immunohistochemical analysis was performed on hippocampus and temporal cortex of 10 patients with histologically verified AD. Pyramidal neuron cytoplasm was immunoreactive in 4 of 4 APOE4 homozygotes, 2 of 3 APOE3/4 heterozygotes, and none of 3 APOE3 homozygotes (P < 0.05). The pattern of staining was highly suggestive of neurofibrillary tangles as the primary immunoreactive structure. These data suggest that differences in neuronal protein modification by HNE may account in part for the APOE-associated stratification of risk for late-onset AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033259      PMCID: PMC1858275     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

Review 1.  On the metabolism of apolipoprotein E and the Alzheimer diseases.

Authors:  A D Roses
Journal:  Exp Neurol       Date:  1995-04       Impact factor: 5.330

Review 2.  Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease.

Authors:  A D Roses
Journal:  Neurobiol Aging       Date:  1994       Impact factor: 4.673

3.  Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.

Authors:  A Furuta; D L Price; C A Pardo; J C Troncoso; Z S Xu; N Taniguchi; L J Martin
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 4.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Intermediates in the Paal-Knorr synthesis of pyrroles. 4-Oxoaldehydes.

Authors:  V Amarnath; K Amarnath; W M Valentine; M A Eng; D G Graham
Journal:  Chem Res Toxicol       Date:  1995-03       Impact factor: 3.739

Review 6.  Pathogenetic studies of hexane and carbon disulfide neurotoxicity.

Authors:  D G Graham; V Amarnath; W M Valentine; S J Pyle; D C Anthony
Journal:  Crit Rev Toxicol       Date:  1995       Impact factor: 5.635

Review 7.  Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease.

Authors:  R W Mahley; B P Nathan; S Bellosta; R E Pitas
Journal:  Curr Opin Lipidol       Date:  1995-04       Impact factor: 4.776

Review 8.  Radical AGEing in Alzheimer's disease.

Authors:  M A Smith; L M Sayre; V M Monnier; G Perry
Journal:  Trends Neurosci       Date:  1995-04       Impact factor: 13.837

9.  Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.

Authors:  W Gsell; R Conrad; M Hickethier; E Sofic; L Frölich; I Wichart; K Jellinger; G Moll; G Ransmayr; H Beckmann
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

10.  Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation.

Authors:  T J Montine; D B Farris; D G Graham
Journal:  J Neuropathol Exp Neurol       Date:  1995-05       Impact factor: 3.685

View more
  53 in total

1.  Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

Authors:  M D Neely; L L Swift; T J Montine
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

2.  Effects of staurosporine, U-73122, wortmannin, 4-hydroxynonenal and sodium azide upon the release of secreted beta-amyloid precursor protein from human platelets in response to thrombin stimulation.

Authors:  H L Hedin; L Nilsson; C J Fowler
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease.

Authors:  A-Ryeong Gwon; Jong-Sung Park; Thiruma V Arumugam; Yong-Kook Kwon; Sic L Chan; Seol-Hee Kim; Sang-Ha Baik; Sunghee Yang; Young-Kwang Yun; Yuri Choi; Saerom Kim; Sung-Chun Tang; Dong-Hoon Hyun; Aiwu Cheng; Charles E Dann; Michel Bernier; Jaewon Lee; William R Markesbery; Mark P Mattson; Dong-Gyu Jo
Journal:  Aging Cell       Date:  2012-04-09       Impact factor: 9.304

4.  The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

Authors:  Justin Legleiter; John D Fryer; David M Holtzman; Andtomasz Kowalewski
Journal:  ACS Chem Neurosci       Date:  2011-10-19       Impact factor: 4.418

Review 5.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

Review 6.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.

Authors:  Sharad S Singhal; Sharda P Singh; Preeti Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-23       Impact factor: 4.219

7.  Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease.

Authors:  M A Bradley; W R Markesbery; M A Lovell
Journal:  Free Radic Biol Med       Date:  2010-02-18       Impact factor: 7.376

Review 8.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

Review 9.  Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Authors:  Hans Lassmann
Journal:  J Neural Transm (Vienna)       Date:  2011-03-05       Impact factor: 3.575

10.  Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

Authors:  Muthuswamy Anantharaman; Jitbanjong Tangpong; Jeffery N Keller; Michael P Murphy; William R Markesbery; Kelley K Kiningham; Daret K St Clair
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.